Loading...
Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients
OBJECTIVES: In a prospective phase IV trial of the first-line oral treatment dimethyl fumarate (DMF), we examined dynamics of neurofilament light (NFL) chain in serum, plasma and cerebrospinal fluid (CSF) samples collected over 12 months from relapsing-remitting multiple sclerosis (RRMS) patients. N...
Na minha lista:
| Udgivet i: | J Neurol Neurosurg Psychiatry |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6902070/ https://ncbi.nlm.nih.gov/pubmed/31611264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp-2019-321321 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|